Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
Open Access
- 1 December 1995
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 96 (6) , 2639-2645
- https://doi.org/10.1172/jci118329
Abstract
After entering the muscle cell, glucose is immediately and irreversibly phosphorylated to glucose-6-phosphate by hexokinases (HK) I and II. Previous studies in rodents have shown that HKII may be the dominant HK in skeletal muscle. Reduced insulin-stimulated glucose uptake and reduced glucose-6-phosphate concentrations in muscle have been found in non-insulin-dependent diabetes mellitus (NIDDM) patients when examined during a hyperglycemic hyperinsulinemic clamp. These findings [correction of finding] are consistent with a defect in glucose transport and/or phosphorylation. In the present study comprising 29 NIDDM patients and 25 matched controls, we tested the hypothesis that HKII activity and gene expression are impaired in vastus lateralis muscle of NIDDM patients when examined in the fasting state. HKII activity in a supernatant of muscle extract accounted for 28 +/- 5% in NIDDM patients and 40 +/- 5% in controls (P = 0.08) of total muscle HK activity when measured at a glucose media of 0.11 mmol/liter and 31 +/- 4 and 47 +/- 7% (P = 0.02) when measured at 0.11 mmol/liter of glucose. HKII mRNA, HKII immunoreactive protein level, and HKII activity were significantly decreased in NIDDM patients (P < 0.0001, P = 0.03, and P = 0.02, respectively) together with significantly decreased glycogen synthase mRNA level and total glycogen synthase activity (P = 0.02 and P = 0.02, respectively). In the entire study population HKII activity estimated at 0.11 and 11.0 mM glucose was inversely correlated with fasting plasma glucose concentrations (r = -0.45, P = 0.004; r = -0.54, P < 0.0001, respectively) and fasting plasma nonesterified fatty acid concentrations (r = -0.46, P = 0.003; r = -0.37, P = 0.02, respectively). In conclusion, NIDDM patients are characterized by a reduced activity and a reduced gene expression of HKII in muscle which may be secondary to the metabolic peturbations. HKII contributes with about one-third of total HK activity in a supernatant of human vastus lateralis muscle.Keywords
This publication has 33 references indexed in Scilit:
- Human Hexokinase II: Sequence and Homology to Other HexokinasesBiochemical and Biophysical Research Communications, 1993
- Mammalian GlucokinaseAnnual Review of Nutrition, 1993
- Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1993
- 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Substrate specific activation by glucose 6-phosphate of the dephosphorylation of muscle glycogen synthaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscleNature, 1990
- An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.Journal of Clinical Investigation, 1988
- On the developmental properties and tissue interactions of hexokinaseMechanisms of Ageing and Development, 1985
- Radioimmunological determination of human C-peptide in serumDiabetologia, 1975